These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 31981649)

  • 21. Evaluation of proton pump inhibitors and risks of gastric cancer.
    Zeng R; Sha W; Wang J; Zhuo Z; Wu H; Leung FW; Chen H
    Gut; 2022 Sep; 71(9):1924-1926. PubMed ID: 34836917
    [No Abstract]   [Full Text] [Related]  

  • 22. Adverse effects of long-term proton pump inhibitor therapy.
    Sheen E; Triadafilopoulos G
    Dig Dis Sci; 2011 Apr; 56(4):931-50. PubMed ID: 21365243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. On gastric polyps, proton pump inhibitors and long-term risks.
    Humphries TJ
    Aliment Pharmacol Ther; 2001 Apr; 15(4):559-60. PubMed ID: 11284786
    [No Abstract]   [Full Text] [Related]  

  • 24. Proton pump inhibitor-associated gastric polyps: a retrospective analysis of their frequency, and endoscopic, histologic, and ultrastructural characteristics.
    Choudhry U; Boyce HW; Coppola D
    Am J Clin Pathol; 1998 Nov; 110(5):615-21. PubMed ID: 9802346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A Case of Cronkhite-Canada syndrome showing resolution with Helicobacter pylori eradication and omeprazole].
    Kim MS; Jung HK; Jung HS; Choi JY; Na YJ; Pyun GW; Ryu JH; Moon IH; Jo MS
    Korean J Gastroenterol; 2006 Jan; 47(1):59-64. PubMed ID: 16434870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Spontaneous resolution of multiple fundic gland polyps after cessation of treatment with omeprazole].
    Kim JS; Chae HS; Kim HK; Cho YS; Park YW; Son HS; Han SW; Choi KY
    Korean J Gastroenterol; 2008 May; 51(5):305-8. PubMed ID: 18516015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cytoprotective activity of anti-ulcer drugs in humans].
    Fiocca F; Schietroma M; Colella A; Costa G; De Santis A; Stabile G; Caruso C; Pianese G; Savino T; Grasso E
    G Chir; 1988 Jun; 9(6):449-50. PubMed ID: 3155207
    [No Abstract]   [Full Text] [Related]  

  • 28. Gastric inflammatory polyposis after long-term intermittent use of nonsteroidal anti-inflammatory drugs and histamine2-receptor antagonists.
    Hizawa K; Takeya T; Yao T; Yamamoto H; Aomi H; Nakahara T; Matsumoto T; Iida M
    Endoscopy; 2005 Jul; 37(7):685. PubMed ID: 16010622
    [No Abstract]   [Full Text] [Related]  

  • 29. Use of Proton Pump Inhibitors and Risks of Fundic Gland Polyps and Gastric Cancer: Systematic Review and Meta-analysis.
    Tran-Duy A; Spaetgens B; Hoes AW; de Wit NJ; Stehouwer CD
    Clin Gastroenterol Hepatol; 2016 Dec; 14(12):1706-1719.e5. PubMed ID: 27211501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [An unknown but potentially serious side effect of proton pump inhibitors: hypomagnesaemia].
    Doornebal J; Bijlsma R; Brouwer RM
    Ned Tijdschr Geneeskd; 2009; 153():A711. PubMed ID: 19930736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Personal review: alarmism or legitimate concerns about long-term suppression of gastric acid secretion?
    Yeomans ND; Dent J
    Aliment Pharmacol Ther; 2000 Mar; 14(3):267-71. PubMed ID: 10735918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of proton pump inhibitor use in gastrointestinal polyps.
    Hsu WH; Wu IC; Kuo CH; Su YC; Lu CY; Kuo FC; Jan CM; Wang WM; Wu DC; Yu FJ
    Kaohsiung J Med Sci; 2010 Feb; 26(2):76-83. PubMed ID: 20123595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Risk of long-term treatment with proton pump inhibitors].
    Mathieu N
    Rev Prat; 2008 Sep; 58(13):1451-4. PubMed ID: 18924330
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proton pump inhibitor use and enteric infections.
    Dial MS
    Am J Gastroenterol; 2009 Mar; 104 Suppl 2():S10-6. PubMed ID: 19262540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proton-pump inhibitors: understanding the complications and risks.
    Malfertheiner P; Kandulski A; Venerito M
    Nat Rev Gastroenterol Hepatol; 2017 Dec; 14(12):697-710. PubMed ID: 28930292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systematic review with meta-analysis: fundic gland polyps and proton pump inhibitors.
    Martin FC; Chenevix-Trench G; Yeomans ND
    Aliment Pharmacol Ther; 2016 Nov; 44(9):915-925. PubMed ID: 27634363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A study on the relation between proton pump inhibitor and gastric giardiasis.
    Kader SA; Mansour AM; Mohran Z; el-Taoil A; Abdalla KF
    J Egypt Soc Parasitol; 1998 Apr; 28(1):149-57. PubMed ID: 9617051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proton pump inhibitors: Adverse effects.
    Sataloff RT
    Ear Nose Throat J; 2010 Dec; 89(12):574-6. PubMed ID: 21174271
    [No Abstract]   [Full Text] [Related]  

  • 39. [The efficacy of proton-pump inhibitors in the treatment of acid-dependent diseases].
    Tkach SM
    Lik Sprava; 1997; (3):30-5. PubMed ID: 9377349
    [No Abstract]   [Full Text] [Related]  

  • 40. Biochemical and pharmacological characteristics of 3-butyryl-8-methoxy-4-[(2-thiophenyl)amino]quinoline, a new proton-pump inhibitor, in rabbit gastric microsomes and in rats.
    Kim KB; Chang MS; Chung YK; Sohn SK; Kim SG; Choi WS
    J Pharm Pharmacol; 1998 May; 50(5):521-9. PubMed ID: 9643446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.